-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cullinan Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2020 to Q3 2025.
- Cullinan Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $9.47M, a 0.39% increase year-over-year.
- Cullinan Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $38.4M, a 7.43% increase year-over-year.
- Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $37.8M, a 24.3% increase from 2023.
- Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $30.4M, a 8.87% increase from 2022.
- Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28M, a 14.7% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)